Immunohistochemical Profile of Endometrial Adenocarcinoma: A Study of 61 Cases and Review of the Literature
- 1 April 2000
- journal article
- review article
- Published by Elsevier in Laboratory Investigation
- Vol. 13 (4) , 379-388
- https://doi.org/10.1038/modpathol.3880062
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- bcl-2 Expression in Endometrial Hyperplasia and CarcinomaGynecologic Oncology, 1996
- Endometrial CarcinomaNew England Journal of Medicine, 1996
- Tumor suppressor p53 is a direct transcriptional activator of the human bax geneCell, 1995
- Bcl-2 and the regulation of programmed cell deathThe Journal of cell biology, 1994
- bcl-2 Protein in Non-Small-Cell Lung CarcinomaNew England Journal of Medicine, 1993
- Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell deathCell, 1993
- Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC)Gynecologic Oncology, 1992
- p53, guardian of the genomeNature, 1992
- p53 Mutations in Human CancersScience, 1991
- The relationship of histologic and histochemical parameters to progesterone receptor status in endometrial adenocarcinomasGynecologic Oncology, 1983